Zhejiang Ausun Pharmaceutical Co., Ltd. (603229) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Ausun Pharmaceutical Co., Ltd.

Why is Zhejiang Ausun Pharmaceutical Co., Ltd. ?

Negative results in Sep 25

NET SALES(Q) At CNY 164.09 MM has Fallen at -16.2%
NET PROFIT(HY) At CNY 88.54 MM has Grown at -23.85%
ROCE(HY) Lowest at 7.96%

With ROE of 7.84%, it has a expensive valuation with a 3.44 Price to Book Value

Over the past year, while the stock has generated a return of 6.92%, its profits have fallen by -32.1%

Underperformed the market in the last 1 year

The stock has generated a return of 6.92% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zhejiang Ausun Pharmaceutical Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Zhejiang Ausun Pharmaceutical Co., Ltd.

9.13%

0.65

33.33%

China Shanghai Composite

15.17%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

13.03%

EBIT Growth (5y)

12.45%

EBIT to Interest (avg)

62.16

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

0.30

Tax Ratio

13.53%

Dividend Payout Ratio

40.14%

Pledged Shares

Institutional Holding

ROCE (avg)

16.62%

ROE (avg)

11.06%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.44

EV to EBIT

48.29

EV to EBITDA

33.93

EV to Capital Employed

4.38

EV to Sales

9.95

PEG Ratio

Dividend Yield

0.99%

ROCE (Latest)

9.06%

ROE (Latest)

7.84%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -2.71% (YoY

NET PROFIT(9M)

Higher at CNY 207.04 MM

CASH AND EQV(HY)

Highest at CNY 2,286.79 MM

-13What is not working for the Company

NET SALES(Q)

At CNY 164.09 MM has Fallen at -16.2%

NET PROFIT(HY)

At CNY 88.54 MM has Grown at -23.85%

ROCE(HY)

Lowest at 7.96%

INTEREST(Q)

At CNY 2.06 MM has Grown at 10.65%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.92 times

PRE-TAX PROFIT(Q)

At CNY 39.16 MM has Fallen at -29.11%

Here's what is working for Zhejiang Ausun Pharmaceutical Co., Ltd.

Cash and Eqv

Highest at CNY 2,286.79 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -2.71% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Ausun Pharmaceutical Co., Ltd.

Net Sales

At CNY 164.09 MM has Fallen at -16.2%

over average net sales of the previous four periods of CNY 195.81 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Interest

At CNY 2.06 MM has Grown at 10.65%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

At CNY 88.54 MM has Grown at -23.85%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Pre-Tax Profit

At CNY 39.16 MM has Fallen at -29.11%

over average net sales of the previous four periods of CNY 55.24 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 0.92 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio